Concetta Scimone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Concetta Scimone has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Rosalia D'ANgelo
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Division of Medical Biotechnologies and Preventive Medicine, University of Messina, Messina, Italy
33 shared publications - Luigi Donato
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Via Consolare Valeria 1, 98125 Messina, Italy
32 shared publications - Antonina Sidoti
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Via Consolare Valeria 1, 98125 Messina, Italy
30 shared publications - Simona Alibrandi
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Division of Medical Biotechnologies and Preventive Medicine, University of Messina, 98125 Messina, Italy
15 shared publications - Carmela Rinaldi
University of Messina
13 shared publications Antonina Sidoti
Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, University of Messina, Messina, Italy
9 shared publications
Latest Publications
- Open Access
- 12 January 2026
- Published by PAGEPress Publications in EuroMediterranean Biomedical Journal
- Vol. 12
POSSIBLE RELATED FUNCTIONS OF THE NON-HOMOLOGOUS CO-REGULATED GENE PAIR PDCD10 AND SERPINI1
Gene expression in mammalians is a very finely controlled mechanism, and bidirectional promoters can be considered one of the most compelling examples of the accuracy of genic expression coordination. As recently reported, a bidirectional promoter regulates the expression of the PDCD10( whose mutations cause familial Cerebral Cavernous Malformations (CCMs) and SERPINI1 gene pair, even though they are non-homologous genes. The aim of this study was to identify any potential common roles of these two coregulated genes. An in-silico approach was used to identify functional correlations, using the BioGraph, IPA® and Cytoscape tools and the KEGG pathway database. The results obtained show that PDCD10 and SERPINI1 may co-regulate some cellular processes, particularly those related to focal adhesion maintenance. All common pathways identified for PDCD10 and SERPINI1 are closely associated with the pathogenic characteristics of CCMs; we thus hypothesize that genes involved in these networks may contribute to the development of CCMs.
- 12 January 2026
- Published by PAGEPress Publications in EuroMediterranean Biomedical Journal
- Vol. 12
Open AccessPOSSIBLE RELATED FUNCTIONS OF THE NON-HOMOLOGOUS CO-REGULATED GENE PAIR PDCD10 AND SERPINI1
Gene expression in mammalians is a very finely controlled mechanism, and bidirectional promoters can be considered one of the most compelling examples of the accuracy of genic expression coordination. As recently reported, a bidirectional promoter regulates the expression of the PDCD10( whose mutations cause familial Cerebral Cavernous Malformations (CCMs) and SERPINI1 gene pair, even though they are non-homologous genes. The aim of this study was to identify any potential common roles of these two coregulated genes. An in-silico approach was used to identify functional correlations, using the BioGraph, IPA® and Cytoscape tools and the KEGG pathway database. The results obtained show that PDCD10 and SERPINI1 may co-regulate some cellular processes, particularly those related to focal adhesion maintenance. All common pathways identified for PDCD10 and SERPINI1 are closely associated with the pathogenic characteristics of CCMs; we thus hypothesize that genes involved in these networks may contribute to the development of CCMs.
- Open Access
- 26 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9430
Computational Evidence for Digenic Contribution of AIPL1 and BBS2 Rare Variants in Inherited Retinal Dystrophy
Inherited retinal dystrophies (IRDs) are clinically and genetically heterogeneous disorders. Most IRDs follow a monogenic inheritance pattern. However, an increasing number of unresolved cases suggest the possible contribution of oligogenic or digenic mechanisms. Here, we report two ultra-rare missense variants—AIPL1 R302L and BBS2 P134R—that co-segregate with early-onset nonsyndromic retinal degeneration in affected individuals from a non-consanguineous family. We performed a multi-level computational investigation to assess whether these variants may act through a convergent pathogenic mechanism. Using AlphaFold2-predicted structures, we modeled both wild-type and mutant proteins, introduced point mutations, and performed energy minimization and validation. FoldX, DynaMut2, and DUET all predicted destabilizing effects at the variant sites, corroborated by local disruption of secondary structure and altered surface electrostatics. Comparative docking (via HDOCK and ClusPro) identified a putative interaction interface between the TPR domain of AIPL1 and the β-sheet face of BBS2. This interface was destabilized in the double-mutant model. At the systems level, transcriptomic profiling confirmed co-expression of AIPL1 and BBS2 in human retina and fetal eye, while functional enrichment analysis highlighted overlapping involvement in ciliary and proteostasis pathways. Network propagation suggested that the two proteins may converge on shared interactors relevant to photoreceptor maintenance. Collectively, these in silico results provide structural and systems-level support for a candidate digenic mechanism involving AIPL1 and BBS2. While experimental validation remains necessary, our study proposes a testable mechanistic hypothesis and underscores the value of computational approaches in uncovering complex genetic contributions to IRDs.
- 26 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9430
Open AccessComputational Evidence for Digenic Contribution of AIPL1 and BBS2 Rare Variants in Inherited Retinal Dystrophy
Inherited retinal dystrophies (IRDs) are clinically and genetically heterogeneous disorders. Most IRDs follow a monogenic inheritance pattern. However, an increasing number of unresolved cases suggest the possible contribution of oligogenic or digenic mechanisms. Here, we report two ultra-rare missense variants—AIPL1 R302L and BBS2 P134R—that co-segregate with early-onset nonsyndromic retinal degeneration in affected individuals from a non-consanguineous family. We performed a multi-level computational investigation to assess whether these variants may act through a convergent pathogenic mechanism. Using AlphaFold2-predicted structures, we modeled both wild-type and mutant proteins, introduced point mutations, and performed energy minimization and validation. FoldX, DynaMut2, and DUET all predicted destabilizing effects at the variant sites, corroborated by local disruption of secondary structure and altered surface electrostatics. Comparative docking (via HDOCK and ClusPro) identified a putative interaction interface between the TPR domain of AIPL1 and the β-sheet face of BBS2. This interface was destabilized in the double-mutant model. At the systems level, transcriptomic profiling confirmed co-expression of AIPL1 and BBS2 in human retina and fetal eye, while functional enrichment analysis highlighted overlapping involvement in ciliary and proteostasis pathways. Network propagation suggested that the two proteins may converge on shared interactors relevant to photoreceptor maintenance. Collectively, these in silico results provide structural and systems-level support for a candidate digenic mechanism involving AIPL1 and BBS2. While experimental validation remains necessary, our study proposes a testable mechanistic hypothesis and underscores the value of computational approaches in uncovering complex genetic contributions to IRDs.
- Open Access
- 24 September 2025
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 109, 101405
Decoding pediatric inherited retinal dystrophies: Bridging genetic complexity and clinical heterogeneity
- 24 September 2025
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 109, 101405
Open AccessDecoding pediatric inherited retinal dystrophies: Bridging genetic complexity and clinical heterogeneity
- Open Access
- 4 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8614
QMR® and Patient Blood-Derived Secretome Modulate RPE microRNA Networks Under Oxidative Stress
Oxidative stress destabilizes microRNA homeostasis in the retinal pigment epithelium (RPE), driving apoptosis and the epithelial-to-mesenchymal transition, which contribute to age-related macular degeneration. We investigated whether Quantum Molecular Resonance (QMR®) electrostimulation, alone or combined with Patient Blood-Derived (PBD) secretoma, can reprogram the RPE miRNome and mitigate stress-induced damage. Human ARPE-19 cells were exposed to tert-butyl-hydroperoxide and treated with QMR®, PBD secretome, or their combination. The deep sequencing of small RNAs at 24 h and 72 h, followed by differential expression and pathway enrichment analyses, delineated treatment-driven miRNA signatures. Oxidative stress deregulated > 50 miRNAs, enriching pro-apoptotic, fibrotic, and inflammatory pathways. QMR® restored roughly 40% of these miRNAs and upregulated additional cytoprotective species such as miR-590-3p, a known regulator of the NF-κB and NLRP3 pathways according to validated target databases. While these observations suggest the potential involvement of inflammatory and stress-related cascades, functional assays will be required to directly confirm such effects. Secretome treatment preferentially increased anti-inflammatory miR-146a-5p and regenerative miR-204-5p while suppressing pro-fibrotic let-7f-5p. Combined QMR® + secretome triggered the broadest miRNA response, normalizing over two-thirds of stress-altered miRNAs. These changes are predicted to influence antioxidant, anti-apoptotic, and anti-fibrotic pathways, although they did not translate into additional short-term cytoprotection compared with QMR® alone. These data indicate that QMR® and PBD secretome modulate complementary miRNA programs that converge on stress response networks. This broader molecular reprogramming may reflect regulatory complementarity, but functional validation is needed to determine whether it provides benefits beyond those observed with QMR® alone. These findings offer molecular insights into potential non-invasive, cell-free strategies for retinal degeneration, although in vivo validation will be required before any clinical translation to Age-Related Macular Degeneration (AMD) therapy.
- 4 September 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (17) , 8614
Open AccessQMR® and Patient Blood-Derived Secretome Modulate RPE microRNA Networks Under Oxidative Stress
Oxidative stress destabilizes microRNA homeostasis in the retinal pigment epithelium (RPE), driving apoptosis and the epithelial-to-mesenchymal transition, which contribute to age-related macular degeneration. We investigated whether Quantum Molecular Resonance (QMR®) electrostimulation, alone or combined with Patient Blood-Derived (PBD) secretoma, can reprogram the RPE miRNome and mitigate stress-induced damage. Human ARPE-19 cells were exposed to tert-butyl-hydroperoxide and treated with QMR®, PBD secretome, or their combination. The deep sequencing of small RNAs at 24 h and 72 h, followed by differential expression and pathway enrichment analyses, delineated treatment-driven miRNA signatures. Oxidative stress deregulated > 50 miRNAs, enriching pro-apoptotic, fibrotic, and inflammatory pathways. QMR® restored roughly 40% of these miRNAs and upregulated additional cytoprotective species such as miR-590-3p, a known regulator of the NF-κB and NLRP3 pathways according to validated target databases. While these observations suggest the potential involvement of inflammatory and stress-related cascades, functional assays will be required to directly confirm such effects. Secretome treatment preferentially increased anti-inflammatory miR-146a-5p and regenerative miR-204-5p while suppressing pro-fibrotic let-7f-5p. Combined QMR® + secretome triggered the broadest miRNA response, normalizing over two-thirds of stress-altered miRNAs. These changes are predicted to influence antioxidant, anti-apoptotic, and anti-fibrotic pathways, although they did not translate into additional short-term cytoprotection compared with QMR® alone. These data indicate that QMR® and PBD secretome modulate complementary miRNA programs that converge on stress response networks. This broader molecular reprogramming may reflect regulatory complementarity, but functional validation is needed to determine whether it provides benefits beyond those observed with QMR® alone. These findings offer molecular insights into potential non-invasive, cell-free strategies for retinal degeneration, although in vivo validation will be required before any clinical translation to Age-Related Macular Degeneration (AMD) therapy.
- Open Access
- 27 August 2025
- Published by MDPI AG in Preprints.org
QMR® and Patient Blood-Derived-Secretome Synergistically Restore RPE microRNA Networks to Repress Apoptotic and Fibrotic Pathways under Oxidative Stress
Oxidative stress destabilizes microRNA homeostasis in retinal pigment epithelium (RPE), driving apoptosis and epithelial-to-mesenchymal transition that contribute to age-related macular degeneration. We investigated whether quantum molecular resonance (QMR®) electrostimulation, alone or combined with Patient Blood-Derived (PBD) secretoma, can reprogram the RPE miRNome and mitigate stress-induced damage. Human ARPE-19 cells were exposed to tert-butyl-hydroperoxide and treated with QMR®, PBD secretome, or their combination. Deep-sequencing of small RNAs at 24 h and 72 h, followed by differential expression and pathway enrichment analyses, delineated treatment-driven miRNA signatures. Oxidative stress deregulated >50 miRNAs, enriching pro-apoptotic, fibrotic, and inflammatory pathways. QMR® restored roughly 40 % of these miRNAs and up-regulated additional cytoprotective species such as miR-590-3p, collectively dampening NF-κB and NLRP3 axes. Secretome treatment preferentially increased anti-inflammatory miR-146a-5p and regenerative miR-204-5p while suppressing pro-fibrotic let-7f-5p. Combined QMR® + secretome triggered the broadest response, normalizing over two-thirds of stress-altered miRNAs and synergistically reinforcing antioxidant, anti-apoptotic, and anti-fibrotic gene networks. These data indicate that QMR® and PBD secretome act through complementary miRNA programs that converge to preserve RPE viability under oxidative insult; their combination offers additive modulation of key survival pathways, supporting development of a non-invasive, cell-free therapeutic strategy for retinal degenerative disorders.
- 27 August 2025
- Published by MDPI AG in Preprints.org
Open AccessQMR® and Patient Blood-Derived-Secretome Synergistically Restore RPE microRNA Networks to Repress Apoptotic and Fibrotic Pathways under Oxidative Stress
Oxidative stress destabilizes microRNA homeostasis in retinal pigment epithelium (RPE), driving apoptosis and epithelial-to-mesenchymal transition that contribute to age-related macular degeneration. We investigated whether quantum molecular resonance (QMR®) electrostimulation, alone or combined with Patient Blood-Derived (PBD) secretoma, can reprogram the RPE miRNome and mitigate stress-induced damage. Human ARPE-19 cells were exposed to tert-butyl-hydroperoxide and treated with QMR®, PBD secretome, or their combination. Deep-sequencing of small RNAs at 24 h and 72 h, followed by differential expression and pathway enrichment analyses, delineated treatment-driven miRNA signatures. Oxidative stress deregulated >50 miRNAs, enriching pro-apoptotic, fibrotic, and inflammatory pathways. QMR® restored roughly 40 % of these miRNAs and up-regulated additional cytoprotective species such as miR-590-3p, collectively dampening NF-κB and NLRP3 axes. Secretome treatment preferentially increased anti-inflammatory miR-146a-5p and regenerative miR-204-5p while suppressing pro-fibrotic let-7f-5p. Combined QMR® + secretome triggered the broadest response, normalizing over two-thirds of stress-altered miRNAs and synergistically reinforcing antioxidant, anti-apoptotic, and anti-fibrotic gene networks. These data indicate that QMR® and PBD secretome act through complementary miRNA programs that converge to preserve RPE viability under oxidative insult; their combination offers additive modulation of key survival pathways, supporting development of a non-invasive, cell-free therapeutic strategy for retinal degenerative disorders.
- 30 May 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-7
First report of PDCD10 somatic mutation in liver cavernous malformation
Background Liver cavernous malformation (CM) is a slow-flow venous malformation in which involved vessels appear tortuous and enlarged, often surrounded by a dense collagenous matrix. Endothelial cells (ECs) of affected vessels show disorganized junctions. Diagnosis usually occurs by computed tomography. Cavernous vessels are also observed in cerebral cavernous malformation (CCM), a disease affecting brain vasculature and occurring following mutations in KRIT1, CCM2 and PDCD10. Coexistence of brain and extra-neurological lesions has been reported. In this study, for the first time, we describe the possible common molecular basis between liver and brain cavernous lesions. Methods and results Genotyping of the three CCM genes was performed on DNA purified from CM ECs. Comparison with DNA purified from control liver ECs allowed to identify several germline variants linked to CCM development. However, a novel PDCD10 rearrangement was uniquely detected in CM ECs. By TOPO-TA Cloning Sequencing, this rearrangement was characterized as an unbalanced translocation, der(7)t(3;7)(q26.1;p12.1). The translocation spans the FAT-homology domain of the PDCD10 protein, crucial for CCM2 binding and the formation of the CCM signalling complex. Conclusions Identification of the PDCD10 somatic mutation suggests a possible common pathogenesis for liver and brain cavernous lesions and allows to increase knowledge on the pathogenesis of liver vascular malformation. Further, for the first time the role of PDCD10 in extra-neurological cavernous lesions was reported.
- 30 May 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-7
First report of PDCD10 somatic mutation in liver cavernous malformation
Background Liver cavernous malformation (CM) is a slow-flow venous malformation in which involved vessels appear tortuous and enlarged, often surrounded by a dense collagenous matrix. Endothelial cells (ECs) of affected vessels show disorganized junctions. Diagnosis usually occurs by computed tomography. Cavernous vessels are also observed in cerebral cavernous malformation (CCM), a disease affecting brain vasculature and occurring following mutations in KRIT1, CCM2 and PDCD10. Coexistence of brain and extra-neurological lesions has been reported. In this study, for the first time, we describe the possible common molecular basis between liver and brain cavernous lesions. Methods and results Genotyping of the three CCM genes was performed on DNA purified from CM ECs. Comparison with DNA purified from control liver ECs allowed to identify several germline variants linked to CCM development. However, a novel PDCD10 rearrangement was uniquely detected in CM ECs. By TOPO-TA Cloning Sequencing, this rearrangement was characterized as an unbalanced translocation, der(7)t(3;7)(q26.1;p12.1). The translocation spans the FAT-homology domain of the PDCD10 protein, crucial for CCM2 binding and the formation of the CCM signalling complex. Conclusions Identification of the PDCD10 somatic mutation suggests a possible common pathogenesis for liver and brain cavernous lesions and allows to increase knowledge on the pathogenesis of liver vascular malformation. Further, for the first time the role of PDCD10 in extra-neurological cavernous lesions was reported.
- Open Access
Mechanotransduction in Development: A Focus on Angiogenesis
Cells respond to external mechanical cues and transduce these forces into biological signals. This process is known as mechanotransduction and requires a group of proteins called mechanosensors. This peculiar class of receptors include extracellular matrix proteins, plasma membrane proteins, the cytoskeleton and the nuclear envelope. These cell components are responsive to a wide spectrum of physical cues including stiffness, tensile force, hydrostatic pressure and shear stress. Among mechanotransducers, the Transient Receptor Potential (TRP) and the PIEZO family members are mechanosensitive ion channels, coupling force transduction with intracellular cation transport. Their activity contributes to embryo development, tissue remodeling and repair, and cell homeostasis. In particular, vessel development is driven by hemodynamic cues such as flow direction and shear stress. Perturbed mechanotransduction is involved in several pathological vascular phenotypes including hereditary hemorrhagic telangiectasia. This review is conceived to summarize the most recent findings of mechanotransduction in development. We first collected main features of mechanosensitive proteins. However, we focused on the role of mechanical cues during development. Mechanosensitive ion channels and their function in vascular development are also discussed, with a focus on brain vessel morphogenesis.
Open AccessMechanotransduction in Development: A Focus on Angiogenesis
Cells respond to external mechanical cues and transduce these forces into biological signals. This process is known as mechanotransduction and requires a group of proteins called mechanosensors. This peculiar class of receptors include extracellular matrix proteins, plasma membrane proteins, the cytoskeleton and the nuclear envelope. These cell components are responsive to a wide spectrum of physical cues including stiffness, tensile force, hydrostatic pressure and shear stress. Among mechanotransducers, the Transient Receptor Potential (TRP) and the PIEZO family members are mechanosensitive ion channels, coupling force transduction with intracellular cation transport. Their activity contributes to embryo development, tissue remodeling and repair, and cell homeostasis. In particular, vessel development is driven by hemodynamic cues such as flow direction and shear stress. Perturbed mechanotransduction is involved in several pathological vascular phenotypes including hereditary hemorrhagic telangiectasia. This review is conceived to summarize the most recent findings of mechanotransduction in development. We first collected main features of mechanosensitive proteins. However, we focused on the role of mechanical cues during development. Mechanosensitive ion channels and their function in vascular development are also discussed, with a focus on brain vessel morphogenesis.
- Open Access
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 27, 4257-4281
Multifaceted disruption of AMPA receptor signaling by CACNG8 variants: Integrated evidence from human genetics and molecular simulation
The Transmembrane AMPA Receptor Regulatory Protein Gamma-8 (TARP γ-8), encoded by CACNG8, regulates AMPA receptor (AMPAR) trafficking, gating, and synaptic localization. Although well-characterized in central synapses, its role in retinal development and disease remains underexplored. This study investigates CACNG8 within the context of inherited retinal dystrophies (IRDs) by integrating human genetics within silico structural analysis. Whole Exome Sequencing (WES) was performed on IRD-affected families with atypical phenotypes—such as residual photoreceptor activity alongside severe optic atrophy or abnormal electroretinogram (ERG) profiles—yet no biallelic mutations in known IRD genes. In all families, rare heterozygous or compound heterozygous CACNG8 variants were identified, including a recurrent stop-gain (p.Arg123Ter) and two missense variants (p.Leu96Val, p.Val102Met), suggesting a potential modifier role. To explore their functional impact, we modeled 14 AMPAR-associated postsynaptic complexes, comparing wild-type and mutant TARP γ-8 configurations. These included auxiliary subunits (CACNG2–7, CNIH2/3), scaffolding proteins (PSD93, PSD95), and regulators (PPP3CA, RIMBPs). Docking and MM-PBSA/MM-GBSA analyses revealed that truncation or destabilization of CACNG8 severely reduced complex stability (ΔΔG > 20 kcal/mol) and altered binding geometry. Molecular dynamics simulations highlighted increased structural perturbations, reduced hydrogen bonding, and greater conformational disorder in mutant assemblies. Grid Inhomogeneous Solvation Theory (GIST) and PCA/TICA analyses further revealed diminished water structuring and constrained conformational landscapes. Altogether, our findings support the potential role of CACNG8 as a genetic modifier in IRDs, pending further validation in larger cohorts. The study illustrates how combining genomic and structural approaches can uncover hidden contributors to complex retinal disorders.
- 1 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 27, 4257-4281
Open AccessMultifaceted disruption of AMPA receptor signaling by CACNG8 variants: Integrated evidence from human genetics and molecular simulation
The Transmembrane AMPA Receptor Regulatory Protein Gamma-8 (TARP γ-8), encoded by CACNG8, regulates AMPA receptor (AMPAR) trafficking, gating, and synaptic localization. Although well-characterized in central synapses, its role in retinal development and disease remains underexplored. This study investigates CACNG8 within the context of inherited retinal dystrophies (IRDs) by integrating human genetics within silico structural analysis. Whole Exome Sequencing (WES) was performed on IRD-affected families with atypical phenotypes—such as residual photoreceptor activity alongside severe optic atrophy or abnormal electroretinogram (ERG) profiles—yet no biallelic mutations in known IRD genes. In all families, rare heterozygous or compound heterozygous CACNG8 variants were identified, including a recurrent stop-gain (p.Arg123Ter) and two missense variants (p.Leu96Val, p.Val102Met), suggesting a potential modifier role. To explore their functional impact, we modeled 14 AMPAR-associated postsynaptic complexes, comparing wild-type and mutant TARP γ-8 configurations. These included auxiliary subunits (CACNG2–7, CNIH2/3), scaffolding proteins (PSD93, PSD95), and regulators (PPP3CA, RIMBPs). Docking and MM-PBSA/MM-GBSA analyses revealed that truncation or destabilization of CACNG8 severely reduced complex stability (ΔΔG > 20 kcal/mol) and altered binding geometry. Molecular dynamics simulations highlighted increased structural perturbations, reduced hydrogen bonding, and greater conformational disorder in mutant assemblies. Grid Inhomogeneous Solvation Theory (GIST) and PCA/TICA analyses further revealed diminished water structuring and constrained conformational landscapes. Altogether, our findings support the potential role of CACNG8 as a genetic modifier in IRDs, pending further validation in larger cohorts. The study illustrates how combining genomic and structural approaches can uncover hidden contributors to complex retinal disorders.
- Open Access
Exploring Trimethylaminuria: Genetics and Molecular Mechanisms, Epidemiology, and Emerging Therapeutic Strategies
Trimethylaminuria (TMAU) is a rare metabolic syndrome caused by the accumulation of trimethylamine in the body, causing odor emissions similar to rotten fish in affected patients. This condition is determined by both genetic and environmental factors, especially gut dysbiosis. The multifactorial nature of this syndrome makes for a complex and multi-level diagnosis. To date, many aspects of this disease are still unclear. Recent research revealed the FMO3 haplotypes’ role on the enzyme’s catalytic activity. This could explain why patients showing only combined polymorphisms or heterozygous causative variants also manifest the TMAU phenotype. In addition, another research hypothesized that the behavioral disturbances showed by patients may be linked to gut microbiota alterations. Our review considers current knowledge about TMAU, clarifying its molecular aspects, the therapeutic approaches used to limit this condition, and the new therapies that are under study.
Open AccessExploring Trimethylaminuria: Genetics and Molecular Mechanisms, Epidemiology, and Emerging Therapeutic Strategies
Trimethylaminuria (TMAU) is a rare metabolic syndrome caused by the accumulation of trimethylamine in the body, causing odor emissions similar to rotten fish in affected patients. This condition is determined by both genetic and environmental factors, especially gut dysbiosis. The multifactorial nature of this syndrome makes for a complex and multi-level diagnosis. To date, many aspects of this disease are still unclear. Recent research revealed the FMO3 haplotypes’ role on the enzyme’s catalytic activity. This could explain why patients showing only combined polymorphisms or heterozygous causative variants also manifest the TMAU phenotype. In addition, another research hypothesized that the behavioral disturbances showed by patients may be linked to gut microbiota alterations. Our review considers current knowledge about TMAU, clarifying its molecular aspects, the therapeutic approaches used to limit this condition, and the new therapies that are under study.
- 31 March 2024
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 218, 105-119
From powerhouse to regulator: The role of mitoepigenetics in mitochondrion-related cellular functions and human diseases
- 31 March 2024
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 218, 105-119
From powerhouse to regulator: The role of mitoepigenetics in mitochondrion-related cellular functions and human diseases